Tag archive for ‘Mylan N.V. (NASDAQ: MYL)’

[Full announcement] Mylan Board Unanimously Rejects Teva bid: low-quality, high-risk, poor record

Board concludes that approach grossly undervalues Mylan, includes Teva stock, and would expose Mylan to a problematic culture and leadership with poor record of delivering shareholder value Proposed More...

Wordpress site Developed by Fixing WordPress Problems